China Sun Pharma Invests in Glucovation, a Glucose Monitoring Company

Hunan China Sun Pharmaceutical Machinery completed a $2 million investment in Glucovation, a San Diego-area medical device maker. Glucovation is developing a novel, low-cost Continuous Glucose Monitoring device that provides blood sugar readings on a phone, pad or watch. In return for its investment, China Sun now owns a 20% stake in Glucovation, and the two companies will establish a JV for production of Glucovation's device. More details.... Stock Symbol: (SHZ: 300216) Share this with colleagues: // //